6-KThe Wire
GENMAB A/S files 6-K
Filed Apr 14, 2026 · 2mo ago · Accession 0001434265-26-000059
Plain English
Genmab A/S announced on April 14, 2026, that it has entered into a definitive agreement to acquire all of the outstanding shares of Cytomx Therapeutics, Inc. for $30.00 per share in cash. This acquisition is expected to significantly expand Genmab's oncology pipeline.
Filing details
- Company
- GENMAB A/S
- Ticker
- GMAB
- CIK
- 1434265
- Form type
- 6-K
- Filing date
- Apr 14, 2026
- Report date
- Apr 14, 2026
- Document
- gmab_20260414x6k.htm
- Size
- 105 KB